Related Experiment Video
Updated: May 10, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Vascular endothelial cell function in catastrophic antiphospholipid syndrome: a case report and review of the
1Division of Haematology, Department of Medicine, McGill University Health Center (MUHC), 1650 Cedar Avenue, Montreal, QC, Canada H3G 1A4.
Abstract:
Catastrophic antiphospholipid syndrome (CAPS) is a rare autoimmune condition, which has been associated with a high mortality rate. However, with current management that includes a combination of anticoagulation, glucocorticoid administration, and plasma exchange, mortality rate has declined. Despite survival improvement with new generation immunosuppressive agents, their mechanisms of action are poorly defined, and CAPS is still considered a high-risk complication in patients known with antiphospholipid antibody syndrome. Herein, we present a case of a 79-year-old male who presented with a myocardial infarct and renal failure secondary to CAPS following a splenectomy for immune thrombocytopenia. Regardless of rapid combination of first-line treatment and rituximab therapy, the patient developed lethal cardiogenic shock secondary to mitral valve papillary muscle necrosis. Discussion of the pathophysiology and avenues of future therapies in CAPS are reported.
Related Concept Videos
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease I: Introduction
Cerebral Edema ll: Pathophysiology
Coronary Artery Disease II: Pathophysiology
